Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)

by PRI | Sep 5, 2024 | News & Events

The Pharmabiotic Research Institute, as a partner of the Human Microbiome Action Consortium, is pleased to announce the publication of the paper, “State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus”, J....

State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus

by PRI | Sep 5, 2024 | PRI Publications

Julie Rodriguez, PhD, Zahra Hassani, PhD, Carolina Alves Costa Silva, PhD,∙Fay Betsou, PhD, Federica Carraturo, PhD,∙Prof Alessio Fasano, MD,∙Mads Israelsen, PhD Anandhi Iyappan, PhD, Aleksander Krag, PhD, Amira Metwaly, PhD, Robert Schierwagen, PhD, Prof Jonel...

FNRS UCLouvain – Metabolism & Nutrition (MNUT)

by PRI | Aug 26, 2024 | Microbiome Research & Technology (public)

Amandine Everard Professor Academic research in microbiome at University (Univeristé Catholique de Louvain – UCL)...

Gut Microbiome Integration in Drug Discovery and Development of Small Molecules

by PRI | Jul 8, 2024 | PRI Publications

Patrick Jimonet , Céline Druart , Stéphanie Blanquet-Diot , Lilia Boucinha, Stephanie Kourula, Françoise Le Vacon, Sylvie Maubant, Sylvie Rabot, Tom Van de Wiele, Frank Schuren, Vincent Thomas, Bernard Walther, Michael Zimmermann; Medicen Microbiome Drug Metabolism...

GenoScreen

by PRI | Apr 10, 2024 | Microbiome Analysis Expertise (service provider)

Nelly Badalato R&D Manager GenoScren is a French biotech with 20+ years of expertise – we develop cutting-edge end-to-end analytical solutions to decipher microbiome (gut, skin, soil) compositions and functions....